Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
32.41
+4.20 (14.89%)
May 20, 2026, 4:00 PM EDT - Market closed
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $23.2 billion as of May 20, 2026. Its market cap has increased by 193.92% in one year.
Market Cap
23.20B
Enterprise Value
18.77B
1-Year Change
193.92%
Ranking
Category
Stock Price
$32.41
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $23.20B, an increase of 4,248.88%. That is a compound annual growth rate of 99.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 23.20B | 53.69% |
| Dec 31, 2025 | 15.09B | 75.25% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 34.32B |
| Revolution Medicines | 31.96B |
| Royalty Pharma | 30.55B |
| Insmed | 23.39B |
| BioNTech SE | 22.85B |
| Incyte | 19.39B |
| Moderna | 19.09B |
| Genmab | 16.45B |